Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ASENSUS SURGICAL, INC. (TRXC)
|
Add to portfolio |
|
|
|
| Price: |
$2.10
| | Metrics |
| OS: |
263.9
|
M
| |
-130
|
% ROE
|
| Market cap: |
$554
|
M
| |
-132
|
% ROIC
|
|
Net cash:
|
$40
|
M
| |
$0.15
|
per share
|
|
EV:
|
$514
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($73.4)
|
M
| |
|
|
|
EBIT
|
($79.4)
|
M
| |
|
|
| EPS |
($0.34)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 7.1 | 8.2 | 3.2 | 8.5 | 24.1 | 7.1 | 1.5 | 46.8 |
| Revenue growth | -13.9% | 159.3% | -62.8% | -64.6% | 238.9% | 368.1% | -96.8% | 11563.6% |
| Cost of goods sold | 10.9 | 11.1 | 5.2 | 20.7 | 16.2 | 6.7 | 1.1 | 46.4 |
| Gross profit | -3.8 | -2.9 | -2.0 | -12.2 | 7.9 | 0.4 | 0.5 | 0.4 |
| Gross margin | -53.4% | -34.8% | -62.7% | -143.0% | 32.9% | 5.4% | 29.6% | 0.9% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 14.8 | 13.4 | 13.1 | 28.0 | 25.7 | 17.5 | 9.2 | 2.9 |
| Research and development | 28.9 | 19.3 | 16.6 | 22.5 | 21.8 | 22.0 | 29.3 | 29.7 |
| General and administrative | 20.2 | 19.3 | 14.1 | 18.8 | 13.9 | 12.3 | 10.8 | 7.8 |
| EBITA | -67.7 | -54.9 | -45.8 | -65.6 | -38.6 | -52.0 | -51.4 | -40.4 |
| EBITA margin | -954.6% | -667.3% | -1442.9% | -768.6% | -160.4% | -731.9% | -3380.6% | -86.3% |
| Amortization of intangibles | 7.7 | 11.3 | 10.8 | 10.3 | 10.9 | 7.9 | 7.0 | 2.2 |
| EBIT | -75.4 | -66.2 | -56.6 | -75.9 | -49.5 | -59.9 | -58.3 | -42.5 |
| EBIT margin | -1063.4% | -804.0% | -1783.1% | -889.4% | -205.4% | -842.4% | -3839.3% | -91.0% |
| Pre-tax income | -75.2 | -62.2 | -60.8 | -157.3 | -65.2 | -148.1 | -125.5 | -48.0 |
| Income taxes | 0.3 | 0.2 | -1.5 | -3.1 | -3.4 | -3.3 | -5.5 | -1.0 |
| Tax rate | | | 2.5% | 2.0% | 5.2% | 2.2% | 4.4% | 2.1% |
| Net income | -75.6 | -62.5 | -60.0 | -154.2 | -61.8 | -144.8 | -120.0 | -46.9 |
| Net margin | -1066.2% | -758.8% | -1890.5% | -1807.5% | -256.3% | -2036.2% | -7898.6% | -100.4% |
| |
| Diluted EPS | ($0.32) | ($0.28) | ($0.85) | ($8.69) | ($3.88) | ($0.97) | ($1.07) | ($0.59) |
| Shares outstanding (diluted) | 236.5 | 227.0 | 70.8 | 17.7 | 15.9 | 148.7 | 112.2 | 79.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|